Matches in Nanopublications for { ?s ?p "[Understanding the molecular action of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, might allow us to perform more effective therapies for hormone-independent advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP548923.RAfAz2AkkNhjun-n83Q6WwseL74zBKecNqXx50-KkfrLk130_assertion description "[Understanding the molecular action of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, might allow us to perform more effective therapies for hormone-independent advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548923.RAfAz2AkkNhjun-n83Q6WwseL74zBKecNqXx50-KkfrLk130_provenance.
- NP548922.RAwG2r0BSACVnLvIIUDQoUSa678yXK1kWVvkHZVWg8cjE130_assertion description "[Understanding the molecular action of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, might allow us to perform more effective therapies for hormone-independent advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548922.RAwG2r0BSACVnLvIIUDQoUSa678yXK1kWVvkHZVWg8cjE130_provenance.